Navigation Links
Gundersen Lutheran Health System is Recognized for Safe Lifting Leadership
Date:3/17/2009

patient and employee safety, Gary Brunslik, Manager of Safety, commented, "Preventing staff injury is good business from the financial standpoint, but also, it is the right thing to do." Kathy Weitekamp, RN, BSN, Care Manager, went on to say, "We've been able to show a 57% decrease in the number of patient handling claims, which we feel is pretty significant. Lost time has gone down 78% and restricted time has gone down 81%, so we're very pleased. Our ceiling lift return on investment has been less than three years." Dr. William Scorby, Medical Director for Employee Health, added, "We also see the safe lifting program as playing an important role in staff retention and recruiting - keeping our experienced nurses safe and injury free while attracting new nurses trained in safe lifting techniques to Gundersen Lutheran."

The objective of the Safe Lifting Leadership Award is to encourage other institutions to follow the lead of "best practices" institutions in their attempts to instill permanent, sustainable culture change - a so-called "culture of safety" - within their organizations. Patient safety, advocacy for healthcare excellence, successful implementation of safe lifting initiatives, and willingness to share results and assist other institutions are among key evaluation criteria for the award.

For more information on the Safe Lifting Leadership Award or Liko's sponsorship of the Safe Lifting Portal, contact Liko - A Hill-Rom Company, 122 Grove Street, Franklin, MA 02038; telephone (888) 545-6671 or (508) 553-3993; fax (508) 528-6642; visit the Liko website at www.liko.com, or visit www.SafeLiftingPortal.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Dan Gilmore |


SOURCE Safe Lifting Portal
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amgen to Present at the Cowen and Company Annual Healthcare Conference
2. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
3. PDHI Launches Short Form of Its ConXus Profile Health Assessment
4. Novavax to Present at Cowen and Company 29th Annual Healthcare Conference
5. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
6. Kibow Biotech Strongly Supports World Kidney Day for Maintenance of Healthy Kidney Function
7. Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
8. Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program
9. Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
10. Onyx Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market ... their offering. The global companion diagnostics ... 22.7% from 2014 to 2019. Factors such as rising ... of companion diagnostics by the pharmaceutical industry, support from ...
(Date:9/18/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... NewsMakers in the Biotech Industry conference on Friday, ... Millennium Broadway Hotel & Conference Center in New ... be accessed at www.meipharma.com . A replay will be ...
(Date:9/18/2014)... Pennsylvanie, 18 septembre 2014 Mapi, ... en 1974, a été depuis 40 ans ... évaluations cliniques traditionnelles par des évaluations recentrées ... sur les impacts économiques des traitements. ... A cours d,une récente conférence ...
Breaking Biology Technology:Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 31974 - 2014 - Mapi fĂȘte ses 40 ans 2
... until further notice, RICHMOND, Va., Oct. 21 Insmed ... that on Thursday, October 16, 2008 NASDAQ issued a notice ... the enforcement of the rules ... Effective immediately, NASDAQ has also suspended the enforcement of the ...
... SAN DIEGO, Oct. 21 Althea Technologies, ... technologies for pharmaceutical,development and manufacturing, announced today ... as its President and Chief Executive Officer. ... Services (PDS) at,Patheon, Inc., will lead Althea,s ...
... Calif., Oct. 21 (11:00 PM PT,Oct. 20) ... announced that,Novartis AG has agreed to acquire from ... for $115 million in cash., "This agreement ... the development,of novel therapeutics using our PEGylation and ...
Cached Biology Technology:Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 2Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 3Althea Technologies Appoints Dr. Shabbir Anik as Chief Executive Officer 2Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 2Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 3Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder 4
(Date:9/18/2014)... matter how many times it,s demonstrated, it,s still ... , But by using a signaling system ... their behavior to suit their population. In short, ... present, and act accordingly. , Once the population ... change from innocuous to pathogenic, or from unhelpful ...
(Date:9/18/2014)... Sept. 18, 2014 -- Arizona turned its newborn screening program ... few short months, earning it the first-ever Newborn Screening Quality ... of Dimes presented Will Humble, M.P.H., Arizona,s Department of Health ... today. Mr. Humble established a policy of full transparency for ... newborn blood samples to the lab for analysis, and set ...
(Date:9/18/2014)... global cycles of carbon and nitrogen comprise all ... and environmental systems have caused imbalances and perturbations ... gases (GHGs). Increased GHGs result in climate changes ... ecosystems, oceans and the atmosphere. Understanding these feedback ... branch of environmental science during the past three ...
Breaking Biology News(10 mins):Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 3Greenhouse gas research enters a new era 2
... NJIT Distinguished Professor Philip R. Goode and the Big Bear ... a deformable mirror in what is called adaptive optics ... an image of a sunspot was published yesterday on the ... day: http://www.cieletespace.fr/node/5752 "This photo ...
... With children going back to school, parents are concerned that ... who dine in a school cafeteria. New research funded ... eat school lunches that are part of the federal government,s ... The same research study found, however, that children who ...
... to locate and identify a gene responsible for a fatal ... may be responsible for a similar rare, fatal disease in ... of the disease in dogs and is the first step ... Dr. Natasha Olby, associate professor of neurology, was part ...
Cached Biology News:See amazing new sun images from NJIT's Big Bear Solar Observatory 2USDA-backed study finds federal school lunches linked to childhood obesity 2USDA-backed study finds federal school lunches linked to childhood obesity 3Researchers find gene responsible for neurodegenerative disease in dogs, possibly in humans 2
Mouse anti-HIV-Imn PND Class: Antibody Product Group: Bacterial and Viral Antigen...
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Rabbit anti-NFkB p105/p50 (Ser337) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: